News
-
-
PRESS RELEASE
LUCIBEL ANNONCE LE LANCEMENT D'UNE AUGMENTATION DE CAPITAL DE 2,15 M EUR AVEC MAINTIEN DU DROIT PRÉFÉRENTIEL DE SOUSCRIPTION
Lucibel lance une augmentation de capital de 2,15 M€ avec maintien du DPS pour renforcer sa structure financière et accélérer son expansion sur les marchés de la Lumière Cosmétique et Scénographique -
PRESS RELEASE
Ondine Biomedical Inc Announces Corporate and Trading Update
Ondine Biomedical (LON:OBI) reports significant revenue growth and commercial momentum in 2023 with doubled revenues and increased number of hospital deployments, including strategic inroads in the UK, Spain, and Australia. The company also announces distribution partnerships and plans for US Phase 3 Clinical Trial -
-
-
-
PRESS RELEASE
KALRAY ACHIEVES SIGNIFICANT IMPROVEMENT IN 2023 ANNUAL RESULTS
Kalray (Euronext Growth Paris: ALKAL) announces strong financial results for 2023, with consolidated revenue up 57% to €25.8 million, gross margin at 67%, and significant EBITDA improvement. Strategic collaborations with Arm in the AI market show promising growth potential -
-
-
